Trends in adoption of total neoadjuvant therapy for locally advanced rectal cancer
Total neoadjuvant chemoradiation (TNT), an accepted strategy for the treatment of locally advanced rectal cancer (LARC), was first included in guidelines in 2018. We aimed to describe trends in, and factors associated with TNT receipt.
Source: American Journal of Surgery - Category: Surgery Authors: Maria Unuvar, Joseph Blansfield, Shengxuan Wang, Rebecca L. Hoffman Tags: Original Research Article Source Type: research
More News: Cancer | Cancer & Oncology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Surgery